Cost Assessment of Antiretroviral Drugs Used in the Treatment of Patients with HIV Infection: Focus on Non-Nucleoside Reverse Transcriptase Inhibitors

By Sabbatani S.  

Clinical Drug Investigation, Vol. 22, Iss. 4, 2002-01 ,pp. : 253-262

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of experimental antiretroviral agents

By Barber Tristan J   Winston Alan  

Future Virology, Vol. 2, Iss. 1, 2007-01 ,pp. : 39-48

Future Medicine

Access to resources Recommend Favorite

Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action

By Bazzoli Caroline   Jullien Vincent   >   Rey Elisabeth   Mentré France   Taburet Anne-Marie  

Clinical Pharmacokinetics, Vol. 49, Iss. 1, 2010-01 ,pp. : 17-45

Adis International

Access to resources Recommend Favorite

Ritonavir: Clinical Pharmacokinetics and Interactions with Other Anti-HIV Agents

By Hsu A.   Granneman G.R.   Bertz R.J.  

Clinical Pharmacokinetics, Vol. 35, Iss. 4, 1998-10 ,pp. : 275-291

Adis International

Access to resources Recommend Favorite

Cardiovascular Risk in Patients with HIV Infection: Impact of Antiretroviral Therapy

By Bente Magny Bergersen  

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 1971-1987

Adis International

Access to resources Recommend Favorite